Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-03
2005-05-03
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S252040, C514S255050, C514S256000, C546S118000, C544S238000, C544S398000, C544S322000, C544S333000, C544S405000
Reexamination Certificate
active
06887885
ABSTRACT:
A compound of formula I, or a pharmaceutically acceptable salt thereof:whereinX1represents hydrogen, halogen, C1-6alkyl, trifluoromethyl or C1-6alkoxy;X2represents hydrogen or halogen;Y represents a chemical bond, an oxygen atom, or a —NH— linkage;Z represents an optionally substituted aryl or heteroaryl group;R1represents hydrocarbon, a heterocyclic group, trifluoromethyl, —SO2Ra, —SO2NRaRb, —CORa, —CO2Raor —CONRaRb; andRaand Rbindependently represent hydrogen, hydrocarbon or a heterocyclic group;pharmaceutical compositions including the compound and methods for treating anxiety, convulsions and cognitive disorders are disclosed.
REFERENCES:
patent: WO 0040583 (2000-07-01), None
Huang Evelyn Mei
Merck Sharp & Dohme Ltd
Thies J. Eric
Winokur Melvin
LandOfFree
Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3367924